GlaxoSmithKline
Treximet sumatriptan and naproxen sodium Tablets Shown to be Effective in Patients Who Previously Had Poor Response to, or Did Not Tolerate, Migraine Treatment with a Short-Acting Triptan
Published in Healthcare Finance, Tax and Law Weekly, July 16th, 2008
New data offer hope for migraine sufferers who report that they have poor response or are intolerant to their migraine therapy. Two studies of migraineurs who reported that they had poor response to, or did not tolerate, short-acting triptans, showed that treatment with Treximet provided sustained pain-free results at two through 24 hours and was generally well-tolerated. These studies were presented today at the 50th Annual Scientific Meeting of the American Headache Society in Boston.
"This information is important to people who have tried and have not yet found relief from short-acting triptans," stated Ninan Mathew, M.D., director of the Houston Headache Clinic and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- a Journey for 9/11
Retired NFL Great George Martin's Historic ''a Journey for 9/11'' Charitable Walk Will End in San Diego on Saturday, June 21 - A.M. Best Co.
BestWeek: After the Fall, Fence Mending at AIG - ACE Group
ACE Makes Three-Year, $720,000 Grant to Freedom from Hunger To Expand Microfinance and Education to Millions in Mexico - Addiction Medicine
Study results from Karolinska Institut, Department of Clinical Neuroscience provide new insights into addiction medicine in adolescents - Adventrx Pharmaceuticals, Inc.
ADVENTRX Settles Dispute With Former Licensee - AE Biofuels, Inc.
AE Biofuels Announces Key Management Appointments - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
